Polydex Pharmaceuticals Limited announced earnings results for the second quarter and six months ended July 31, 2018. For the quarter, the company reported sales of $1,267,481 against $1,274,622 for the same period a year ago. Net income was $60,149 against net loss of $20,095,000 for the same period a year ago. Basic and diluted income per share was $0.02 against basic and diluted loss per share of $0.01 for the same period a year ago. For the six months, the company reported sales of $2,747,786 against $2,534,707 for the same period a year ago. Net income was $165,097 against $129,064 for the same period a year ago. Basic and diluted income per share was $0.05 against $0.04 for the same period a year ago.